JR
Jason Rhodes
Chairman (and founding CEO) at Generation Bio
JR
Jason Rhodes
Chairman (and founding CEO) at Generation Bio
Cambridge, Massachusetts
Overview
Work Experience
Partner
2014 - Current
Executive Chair (and founding CEO)
2020
Chairman (and founding CEO)
2016
www.generationbio.com
Chairman (and founding CEO)
2017
Presidential Advisory Council, Member
2009 - 2022
Chairman (and founding CEO)
2016 - 2020
President and CFO
2010 - 2014
Vice President, Business Development
2007 - 2010
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNAi. Led strategic collaborations with Takeda, GSK, Kyowa Hakko Kirin, Medtronic, Cubist and Roche, and spin out of Regulus (RGLS).
Partner
2001 - 2007
Biotech venture capital arm of Fidelity Investments. Led investments in therapeutics companies including FoldRx, acquired by Pfizer.